Three mild cases of coronavirus disease 2019 treated with saikatsugekito, a Japanese herbal medicine

Cases: We report cases of three patients infected with mild coronavirus disease 2019 (COVID-19) treated only with Kampo medicine and discharged from the hospital without symptom exacerbation. Case 1: A 41-year-old healthy female suffering from headache, sore throat, and fever. Case 2: A 16-year-old healthy female sufferking from nasal congestion and taste disorder. Case 3: A 12-year-old healthy male suffering from nasal congestion and taste disorder. Outcome: The three patients were prescribed saikatsugekito. Cases 1 and 3 initially presented with white and yellow tongue coating, which disappeared several days after the prescription of saikatsugekito. All three patients were discharged from the hospital without symptom exacerbation. Conclusion: We believe that treatment with Kampo medicine, which is relatively safe clinically and has few side effects, should be taken at an early stage of COVID-19 along with coping therapy. And we think that saikatsugekito may contribute to prevent the worsening of COVID-19.